HL

Human Longevity and Performance Impact Venture Fund

North America, California, United States, San Diego

Description

Human Longevity and Performance Impact Venture Fund is a longevity focused early stage venture capital fund.

Investor Profile

Human Longevity and Performance Impact Venture Fund has made 2 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • Hong Kong (50%)
  • United States (50%)

Industry Focus

  • Health Care
  • Biotechnology
  • Artificial Intelligence (Ai)
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Human Longevity and Performance Impact Venture Fund frequently co-invest with?

EV
North America, Maryland, United States, Rockville
Co-Investments: 1
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 1
Excelerate Health Ventures
North America, North Carolina, United States, Durham
Co-Investments: 1
Boston Millennia Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
Fusion Fund
North America, California, United States, Palo Alto
Co-Investments: 1
Bold Capital Partners
North America, California, United States, Santa Monica
Co-Investments: 1
Longevity Vision Fund
North America, New York, United States, New York
Co-Investments: 1
Formic Ventures
North America, California, United States, San Francisco
Co-Investments: 1
LongeVC
Europe, Ticino, Switzerland, Lugano
Co-Investments: 1
Emerging Technology Partners
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Human Longevity and Performance Impact Venture Fund?

Huma.AI

Los Altos, California, United States

Huma is a provider of business intelligence platform built to automate healthcare through human language.

Artificial Intelligence (AI)Health CareInformation Technology
Series AFeb 7, 2022
Amount Raised: $9,500,000
Deep Longevity

Hong Kong, Hong Kong Island, Hong Kong

Deep Longevity is a biotechnology company transforming longevity R&D through AI-discovered biomarkers of aging.

BiotechnologyHealth Care
Series AJul 14, 2020